Thomas Schaser

Bergisch Gladbach, NW 51429, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

A novel pseudotype derived of the canine distemper virus for adapter-mediated lentiviral transduction in vivo.

A novel pseudotype derived of the canine distemper virus for adapter-mediated lentiviral transduction in vivo.

Journal: Molecular therapy. Methods & clinical development

Published: September 19, 2024

CAR'TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatment.

CAR'TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatment.

Journal: Molecular therapy. Oncology

Published: January 07, 2024

Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy.

Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy.

Journal: Molecular therapy. Methods & clinical development

Published: November 30, 2023

CD62L as target receptor for specific gene delivery into less differentiated human T lymphocytes.

CD62L as target receptor for specific gene delivery into less differentiated human T lymphocytes.

Journal: Frontiers in immunology

Published: March 10, 2023

Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma.

Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma.

Journal: Frontiers in immunology

Published: March 02, 2023

Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cells.

Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cells.

Journal: Oncoimmunology

Published: November 17, 2022

Adapter-Mediated Transduction with Lentiviral Vectors: A Novel Tool for Cell-Type-Specific Gene Transfer.

Adapter-Mediated Transduction with Lentiviral Vectors: A Novel Tool for Cell-Type-Specific Gene Transfer.

Journal: Viruses

Published: August 31, 2022

Automated, scaled, transposon-based production of CAR T cells.

Automated, scaled, transposon-based production of CAR T cells.

Journal: Journal for immunotherapy of cancer

Published: August 23, 2022

Automated generation of gene-edited CAR T cells at clinical scale.

Automated generation of gene-edited CAR T cells at clinical scale.

Journal: Molecular therapy. Methods & clinical development

Published: October 27, 2020

Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells.

Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells.

Journal: Molecular therapy. Methods & clinical development

Published: August 20, 2020

Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing.

Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing.

Journal: Human gene therapy

Published: October 04, 2019

Highly Efficient and Selective CAR-Gene Transfer Using CD4- and CD8-Targeted Lentiviral Vectors.

Highly Efficient and Selective CAR-Gene Transfer Using CD4- and CD8-Targeted Lentiviral Vectors.

Journal: Molecular therapy. Methods & clinical development

Published: October 08, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026